PCVX VAXCYTE Hires Ex-Pfizer Vaccine Chief, Narrows VAX-31 Data Timing Vaxcyte named Luis Jodar CMO and David McAvoy CLO, and now expects OPUS-1 Phase 3 topline data by the end of October 2026.
